Personalis, Inc. Deferred Foreign Income Tax Expense (Benefit)
Personalis, Inc. (PSNL) reported Deferred Foreign Income Tax Expense (Benefit) of -$2.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-02-26
- Personalis, Inc. deferred foreign income tax expense (benefit) for fiscal 2025 was -$2.00K.
- Personalis, Inc. deferred foreign income tax expense (benefit) for fiscal 2024 was -$1.00K, a 101.85% decline from fiscal 2023.
- Personalis, Inc. deferred foreign income tax expense (benefit) for fiscal 2023 was $54.00K.
- Personalis, Inc. deferred foreign income tax expense (benefit) for fiscal 2022 was -$31.00K.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$2.00K 10-K · filed 2026-02-26 |
| 2024-12-31 | -$1.00K 10-K · filed 2026-02-26 |
| 2023-12-31 | $54.00K 10-K · filed 2025-02-27 |
| 2022-12-31 | -$31.00K 10-K · filed 2024-02-28 |
| 2021-12-31 | -$29.00K 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |